Prostaglandin I2 is less relaxant than prostaglandin E2 on the lamb ductus arteriosus.
Prostaglandin (PG) I2 and its stable metabolite, 6-keto-PGF1alpha, were tested on the isolated ductus arteriosus from mature fetal lambs. PGI2 relaxed the ductus in high doses (threshold 10(-6)M) and its activity disappeared on standing at room temperature for 30 minutes. 6-keto-PGF1alpha was inactive at all doses. By contrast, PGE2 produced a dose-dependent relaxation over a range between 10(-10) and 10(-6)M. These findings confirm that PGE2 is the most potent ductal relaxant among the known derivatives of arachidonic acid. PGE2 probably maintains ductus patency in the fetus and, together with PGE1, remains the compound of choice in the management of newborns requiring a viable ductus for survival.
D000818:Animals; D003470:Culture Media; D004373:Ductus Arteriosus / Q000187:drug effects*; D011464:Epoprostenol / Q000494:pharmacology*; D005260:Female; D007213:Indomethacin; D009130:Muscle, Smooth / Q000187:drug effects*; D010101:Oxygen Consumption; D010974:Platelet Aggregation / Q000187:drug effects; D011247:Pregnancy; D011453:Prostaglandins / Q000494:pharmacology*; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology; D012756:Sheep
D003470:Culture Media; D011453:Prostaglandins; D011459:Prostaglandins E, Synthetic; D011461:Prostaglandins F, Synthetic; D011464:Epoprostenol; D007213:Indomethacin